Filing Details
- Accession Number:
- 0001179110-18-009838
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-19 16:52:20
- Reporting Period:
- 2018-07-18
- Accepted Time:
- 2018-07-19 16:52:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1733094 | Young Kwon | C/O Momenta Pharmaceuticals, Inc. 301 Binney Street Cambridge MA 02142 | Svp, Corporate Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-07-18 | 8,000 | $13.26 | 122,624 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-07-18 | 8,000 | $29.21 | 114,624 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-07-18 | 8,500 | $15.44 | 123,124 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-07-18 | 8,500 | $29.43 | 114,624 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-07-18 | 9,164 | $17.96 | 123,788 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-07-18 | 9,164 | $29.46 | 114,624 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-07-18 | 2,500 | $13.02 | 117,124 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-07-18 | 2,500 | $29.30 | 114,624 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-07-18 | 4,000 | $21.56 | 118,624 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-07-18 | 4,000 | $29.40 | 114,624 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-07-18 | 3,000 | $28.90 | 111,624 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option(Right to Buy) | Disposition | 2018-07-18 | 8,000 | $0.00 | 8,000 | $13.26 |
| Common Stock | Stock Option(Right to Buy) | Disposition | 2018-07-18 | 8,500 | $0.00 | 8,500 | $15.44 |
| Common Stock | Stock Option(Right to Buy) | Disposition | 2018-07-18 | 9,164 | $0.00 | 9,164 | $17.96 |
| Common Stock | Stock Option(Right to Buy) | Disposition | 2018-07-18 | 2,500 | $0.00 | 2,500 | $13.02 |
| Common Stock | Stock Option(Right to Buy) | Disposition | 2018-07-18 | 4,000 | $0.00 | 4,000 | $21.56 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 11,500 | 2015-02-22 | 2021-02-22 | No | 4 | M | Direct |
| 0 | 2016-02-14 | 2022-02-14 | No | 4 | M | Direct |
| 4,822 | 2018-02-18 | 2024-02-18 | No | 4 | M | Direct |
| 19,725 | 2018-05-18 | 2025-02-18 | No | 4 | M | Direct |
| 10,000 | 2018-05-11 | 2025-08-11 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades at prices ranging from $28.90 to $29.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
